Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 2,000.00
spinner
Single User $ 3,000.00
spinner
Multiple User $ 4,000.00
spinner
Corporate User $ 6,000.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Acromegaly Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018


 

Available formats:    

StumbleUponEmail

Acromegaly Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018

 

Overview:

Acromegaly is a rare disorder caused excessive production of Growth Hormone (GH) by pituitary gland, due to this tissues and bones in the body grows more rapidly which may leads to abnormal hands and feet. When acromegaly is caused before puberty it is called as Gigantism. Early symptoms of Acromegaly includes swollen hands and feet, sleep apnea, difficulty in sleeping, numbness and weakness in hands, changes in skin etc.

Acromegaly can be diagnosed by brain scans and blood tests like IGF test, Glucose Tolerance test. Acromegaly can be treated by surgery, radiation therapy and medications like Somatostatin analogs, GH receptor antagonists and Dopamine agonists.

 

Segmentation:

By Trial Phase, Acromegaly pipeline drugs are segmented as:

  • Preclinical Trials
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

By Company, Acromegaly pipeline drugs are segmented as:

  • Novartis
  • Italfarmaco
  • Chiasma, Inc.
  • Ipsen
  • Endo Pharmaceuticals
  • Pfizer
  • AmbriliaBiopharma, Inc.
  • Others

By Drugs, Acromegaly pipeline drugs are segmented as:

  • Octreotide
  • Pasireotide
  • Lanreotide
  • Sandostatin
  • Somatuline
  • Pegvisomant
  • Others

By Route of Administration, Acromegaly pipeline drugs are segmented as:

  • Oral
  • Parenteral

 

Space Analysis:

  • In March 2015, Novartis Pharmaceuticals commenced Phase IIIb Multicenter, open-label, single arm study to evaluate the efficacy and safety of Pasireotide in Patients with acromegaly inadequately controlled with first generation somatostatin analogues.

 

Report Description:

Acromegaly Disease Pipeline Drugs Assessment report studies the various therapeutics under clinical development for Acromegaly treatment along with targets for various drug candidate. The report provides plethora of information pertaining to trail phases, companies involved in the Acromegaly disease pipeline drugs development. This report studies the dynamics of the Acromegaly Disease Pipeline Drugs i.e. drivers, challenges and opportunities which are significantly impacting the product development. The report provides various information pertaining the clinical trials such as designation, grants, patents, and technology among others. Moreover, the report on Acromegaly disease pipeline drugs assessment comprehensively presents the geographic location, trial status information along with key players involved in the therapeutics development.

 

Key Features of the Report:

  • Provides the information related to universities and research institutes working in the therapeutics development
  • Report comprehensively covers the all active and discontinued studies
  • Studies the entire pipeline with special emphasis on companies actively involved in the therapeutics development
  • Presents the prominent targets for drug development in each stage of clinical trial
  • Provides the in-depth analysis on the each drug candidates in the clinical trial phases
  • Novartis
  • Italfarmaco
  • Chiasma, Inc.
  • Ipsen
  • Endo Pharmaceuticals
  • Pfizer
  • AmbriliaBiopharma, Inc.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553